If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnite Regulatory News (UTG)

Share Price Information for Unite (UTG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 963.00
Bid: 960.50
Ask: 961.00
Change: -15.50 (-1.58%)
Spread: 0.50 (0.052%)
Open: 980.50
High: 983.50
Low: 960.00
Prev. Close: 978.50
UTG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Apr 2021 15:20

RNS Number : 1892V
Unite Group PLC (The)
12 April 2021
 

THE UNITE GROUP PLC (THE "COMPANY")

12 April 2021

GRANT OF OPTIONS AND DIRECTORS' INTERESTS

Pursuant to the long term incentive plan of the Company, awards have been granted to the Company's Executive Directors, namely Mr Richard Smith (Chief Executive Officer) and Mr Joe Lister (Chief Financial Officer) on 12 April 2021 as follows:

Director

Nil cost options

HMRC approved options

Richard Smith

 

87,070

 

479

Joe Lister

 

70,850

 

479

 

The HMRC approved options were awarded at an option price of 1083.5p per share, being the closing middle market price of the shares on the day prior to the date on which the options were granted.

In accordance with the Plan Rules and Remuneration Policy, and consistent with the approach taken in 2020 due to the ongoing impact of the Covid-19, the Committee will retain overarching discretion to approve the vesting of these awards and will carefully scrutinise overall outcomes to ensure that they reflect the performance of the Company and the experience of stakeholders over the period, and do not reward windfall gains.

The number of shares in respect of which Messrs Smith and Lister may exercise these options will be determined following the three year measurement period ending 31 December 2023, by reference to the EPRA adjusted earnings per share, total accounting return and total shareholder return performance of the Company over this period. Due to continued Covid-19 uncertainty and the implications this has for being able to set credible and appropriately stretching targets, the Committee has taken the decision to delay target setting for the EPRA adjusted earnings per share element of the award. The Committee expects to be in a position to set and disclose targets for this one-third of the award within six months of grant and will announce further details at this later date. Total accounting return and total shareholder return targets are based on the Company's relative performance, with threshold and maximum vesting requiring performance in line with the median and upper quartile ranked constituent of the FTSE350 Real Estate Supersector Index respectively, in line with market best practice.

A two year holding period applies to these options, such that options vesting may only be exercised from 12 April 2026, the fifth anniversary of the date of grant.

This notification is made in accordance with the requirements of the Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Richard Smith

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

The Unite Group plc

b)

 

LEI

 

 

213800BBUUWVDH9YI827

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

GB0006928617

 

b)

 

Nature of the transaction

 

 

Grant of LTIP options

 

 

 

 

c)

 

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

£10.835

 

87,070

£10.835

479

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

87,549

 

£10.835

e)

 

Date of the transaction

 

 

12 April 2021

 

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Joe Lister

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

The Unite Group plc

b)

 

LEI

 

 

213800BBUUWVDH9YI827

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

GB0006928617

 

b)

 

Nature of the transaction

 

Grant of LTIP options

 

 

 

c)

 

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

£10.835

70,850

£10.835

479

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

71,329

 

£10.835

 

e)

 

Date of the transaction

 

 

12 April 2021

 

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

For further information, please contact:

Unite Students

Christopher Szpojnarowicz, Company Secretary

 

 

Tel: +44 117 302 7120

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKBBDQBKDAQD
Date   Source Headline
10th May 20249:00 amRNSDirector Declaration
26th Apr 20246:00 pmRNSHolding(s) in Company
25th Apr 20245:06 pmRNSScrip Reference Share Price & Enhanced Scrip
16th Apr 20241:05 pmRNSHolding(s) in Company
15th Apr 20243:20 pmRNSPublication of Base Listing Particulars
11th Apr 202412:05 pmRNSDirector/PDMR Shareholding
10th Apr 20243:15 pmRNSDirector/PDMR Shareholding
10th Apr 20243:00 pmRNS2023 Annual Report and Notice of AGM
9th Apr 20247:00 amRNSTRADING UPDATE AND Q1 FUND VALUATIONS
28th Mar 20244:00 pmRNSTotal Voting Rights
11th Mar 20248:30 amRNSDirector Declaration
6th Mar 20249:30 amRNSDirector/PDMR Shareholding
29th Feb 20244:52 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
19th Feb 20247:00 amRNSUniversity Joint Venture
31st Jan 20243:30 pmRNSTotal Voting Rights
10th Jan 20249:00 amRNSNotice of Results
9th Jan 20247:00 amRNSTRADING UPDATE AND Q4 FUND VALUATIONS
2nd Jan 202410:00 amRNSTotal Voting Rights
1st Dec 20232:00 pmRNSBlock listing Interim Review
30th Nov 20234:00 pmRNSTotal Voting Rights
16th Nov 20232:00 pmRNSDirector/PDMR Shareholding
31st Oct 20234:30 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSTotal Voting Rights
20th Oct 20232:00 pmRNSResults of Scrip Dividend Election
5th Oct 20237:01 amRNSTrading Update and Q3 Fund Valuations
5th Oct 20237:00 amRNSCEO Succession & Board Changes
2nd Oct 20234:00 pmRNSDirector/PDMR Shareholding
29th Sep 202311:00 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSSCRIP REFERENCE SHARE PRICE-2023 INTERIM DIVIDEND
20th Sep 20232:10 pmRNSHolding(s) in Company
15th Sep 20236:31 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSNew 800-bed development in Glasgow
31st Aug 20232:00 pmRNSTotal Voting Rights
1st Aug 202310:00 amRNSHolding(s) in Company
31st Jul 20233:00 pmRNSTotal Voting Rights
27th Jul 202311:13 amRNSHolding(s) in Company
27th Jul 202311:00 amRNSDirector/PDMR Shareholding
25th Jul 20236:00 pmRNSUnite Group
25th Jul 20237:00 amRNSResults of Capital Raise
24th Jul 20234:41 pmRNSRetail offer of new ordinary shares
24th Jul 20234:40 pmRNSProposed placing of new ordinary shares
24th Jul 20234:38 pmRNSInterim Results
10th Jul 20237:00 amRNSTRADING UPDATE AND Q2 FUND VALUATIONS
30th Jun 20235:10 pmRNSTotal Voting Rights
23rd Jun 20239:00 amRNSNotice of Interim Results
21st Jun 20235:24 pmRNSHolding(s) in Company
16th Jun 20234:30 pmRNSDirector/PDMR Shareholding
12th Jun 20232:30 pmRNSAdditional Listing
1st Jun 20234:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.